Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Israel Journal of Medical Sciences
|
April 1, 1976
Lysis and necrosis: analysis of two cytotoxic phenomena mediated by lymphocytes
H Ginsburg, Y Naot, N Hollander
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1988
Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins
N Hollander, P Selvaraj, T A Springer
The Journal of Experimental Medicine
|
September 1, 1980
Blocking effect of lyt-2 antibodies on T cell functions
N Hollander, E Pillemer, I L Weissman
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1981
Effects of Lyt antibodies on T-cell functions: augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2
N Hollander, E Pillemer, I L Weissman
Cancer Immunology, Immunotherapy : CII
|
April 15, 1999
Rejection of tumors of the B cell lineage by idiotype-vaccinated mice
J Haimovich, T Kukulansky, B Weissman, et al.
Cancer Immunology, Immunotherapy : CII
|
June 13, 2001
Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma
R Aviram, N Raz, T Kukulansky, et al.
International Journal of Cancer
|
October 15, 1978
An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production
N Isakov, S Segal, N Hollander, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1995
Light chain loss and reexpression leads to idiotype switch. Surrogate light chains are probably responsible for this process
Y Caspi, M Taya, N Hollander, et al.
Clinical and Experimental Immunology
|
November 6, 2012
Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma
S Manzur, S Cohen, J Haimovich, et al.
International Journal of Cancer
|
March 15, 1979
An immunoregulatory factor associated with spleen cells from tumor-bearing animals. III. Characterization of the factor's target cells
N Isakov, N Hollander, S Segal, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Israel Journal of Medical Sciences
|
April 1, 1976
Lysis and necrosis: analysis of two cytotoxic phenomena mediated by lymphocytes
H Ginsburg, Y Naot, N Hollander
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1988
Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins
N Hollander, P Selvaraj, T A Springer
The Journal of Experimental Medicine
|
September 1, 1980
Blocking effect of lyt-2 antibodies on T cell functions
N Hollander, E Pillemer, I L Weissman
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1981
Effects of Lyt antibodies on T-cell functions: augmentation by anti-Lyt-1 as opposed to inhibition by anti-Lyt-2
N Hollander, E Pillemer, I L Weissman
Cancer Immunology, Immunotherapy : CII
|
April 15, 1999
Rejection of tumors of the B cell lineage by idiotype-vaccinated mice
J Haimovich, T Kukulansky, B Weissman, et al.
Cancer Immunology, Immunotherapy : CII
|
June 13, 2001
Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma
R Aviram, N Raz, T Kukulansky, et al.
International Journal of Cancer
|
October 15, 1978
An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production
N Isakov, S Segal, N Hollander, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1995
Light chain loss and reexpression leads to idiotype switch. Surrogate light chains are probably responsible for this process
Y Caspi, M Taya, N Hollander, et al.
Clinical and Experimental Immunology
|
November 6, 2012
Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma
S Manzur, S Cohen, J Haimovich, et al.
International Journal of Cancer
|
March 15, 1979
An immunoregulatory factor associated with spleen cells from tumor-bearing animals. III. Characterization of the factor's target cells
N Isakov, N Hollander, S Segal, et al.
Page
of 7